glp-1 obesity drug news today october 2025 Retatrutide, the next generation of from Eli Lilly, helped participants lose an average of 71.2 pounds and reduce knee arthritis pain in a late-stage clinical trial, the company announced. In GLP-1s for Weight Loss: What

It has shown promise in managing: Leaky gut syndrome Gastritis and ulcers Irritable Bowel Syndrome (IBS) Inflammatory Bowel Disease (IBD) Stress-related gut dysfunction Gut-mediated mood imbalance and brain fog By restoring gut integrity, it enhances nutrient absorption, immune balance, and emotional well-being

The good news is, most of them are manageable with the right support

Jones, G., Jenkinson, C., & Kennedy, S

The pharmacokinetic profile of baclofen, characterized by moderate oral bioavailability, limited blood-brain barrier penetration, predominant renal elimination, and a short half-life necessitating frequent dosing, fundamentally informs clinical decision-making regarding route selection, dose titration, and special population considerations